Log in

NASDAQ:MRSNMersana Therapeutics Insider Trades

-0.56 (-2.47 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $22.10
50-Day Range
MA: $18.33
52-Week Range
Now: $22.10
Volume772,753 shs
Average Volume1.16 million shs
Market Capitalization$1.48 billion
P/E RatioN/A
Dividend YieldN/A

Insider Trades

Mersana Therapeutics (NASDAQ:MRSN) Insider Buying and Selling Activity

Insider Ownership Percentage: 5.30%

Insider Buying and Selling by Quarter

Mersana Therapeutics (NASDAQ MRSN) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/1/2020Lawrence M AllevaDirectorBuy1,085$22.95$24,900.75385  
4/13/2020Scott D SandellMajor ShareholderSell20,914$8.50$177,769.00  
4/7/2020Andrew A F HackDirectorBuy3,445,667$9.43$32,492,639.81538,599  
3/5/2019Enterprise Associates 14 NewMajor ShareholderBuy3,750,000$4.00$15,000,000.00  
9/24/2018Timothy B LowingerInsiderSell3,500$11.63$40,705.00  
8/27/2018Timothy B LowingerInsiderSell3,500$13.15$46,025.00  
7/23/2018Timothy B LowingerInsiderSell3,500$11.06$38,710.00  
7/3/2017M James BarrettMajor ShareholderBuy1,000,000$15.00$15,000,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 7/6/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.